Neurology:血管周围间隙扩大的分布情况或可预测不同类型小血管病

2013-04-25 Neurology 丁香园

血管周围间隙扩大与小血管病密切相关,来自曼彻斯特神经研究所的Sergi Martinez-Ramirez等学者研究了脑内DPVS的不同分布情况,结果发表在2013年4月23日的Neurology杂志上。本研究目的为评估脑血管周围间隙扩大(DPVS)是否为脑淀粉样血管病和高血压血管病等小血管疾病的标识。结果发现:血管周围间隙扩大的分布情况或可用于预测不同类型的脑小血管病。该研究的患者招募人群为一记忆

血管周围间隙扩大与小血管病密切相关,来自曼彻斯特神经研究所的Sergi Martinez-Ramirez等学者研究了脑内DPVS的不同分布情况,结果发表在2013年4月23日的Neurology杂志上。本研究目的为评估脑血管周围间隙扩大(DPVS)是否为脑淀粉样血管病和高血压血管病等小血管疾病的标识。结果发现:血管周围间隙扩大的分布情况或可用于预测不同类型的脑小血管病。
该研究的患者招募人群为一记忆门诊的的单中心前瞻性队列研究。所有患者均进行结构性高分辨MRI检查,并在扫描检查1年内进行临床特征评估。DPVS的评估采用T1序列分别监测基底节区及脑白质去的血管周围间隙的扩大情况,利用4分半定量(即大于或小于2分)评分系统。DPVS分为高度组(评分大于2分)及低度组(评分小于或等于2分)。分别研究基底节区和白质区DPVS高度组的独立危险因素。
研究共纳入89例患者,平均年龄为72.7 ± 9.9岁,57%为女性患者。脑白质区DPVS高度组与低度组相比,脑叶微出血的发生率更高(45.5%比28.4%)。基底节区DPVS高度组患者与年龄增大、高血压和脑白质高信号区域增大相关。多元分析显示,脑叶微出血数量的增加为白质区高度DPVS的独立预测因素(优势比为1.53,95%可信区间为1.06–2.21,p = 0.02);与此类似,高血压是基底节区高度DPVS的独立危险因素(优势比为9.4,95%可信区间 CI为1–85.2, p = 0.04)。
结果显示利用白质区DPVS与微出血的相关性及基底节区DPVS与高血压的相关性,血管周围间隙扩大或可以用来预测认知损伤患者潜在小血管病(如脑淀粉样血管病和高血压血管病)的发病情况。
血管相关的拓展阅读:


Topography of dilated perivascular spaces in subjects from a memory clinic cohort.
OBJECTIVE
To investigate whether the topography of dilated perivascular spaces (DPVS) corresponds with markers of particular small-vessel diseases such as cerebral amyloid angiopathy and hypertensive vasculopathy.
METHODS
Patients were recruited from an ongoing single-center prospective longitudinal cohort study of patients evaluated in a memory clinic. All patients underwent structural, high-resolution MRI, and had a clinical assessment performed within 1 year of scan. DPVS were rated in basal ganglia (BG-DPVS) and white matter (WM-DPVS) on T1 sequences, using an established 4-point semiquantitative score. DPVS degree was classified as high (score > 2) or low (score ≤ 2). Independent risk factors for high degree of BG-DPVS and WM-DPVS were investigated.
RESULTS
Eighty-nine patients were included (mean age 72.7 ± 9.9 years, 57% female). High degree of WM-DPVS was more frequent than low degree in patients with presence of strictly lobar microbleeds (45.5% vs 28.4% of subjects). High BG-DPVS degree was associated with older age, hypertension, and higher white matter hyperintensity volumes. In multivariate analysis, increased lobar microbleed count was an independent predictor of high degree of WM-DPVS (odds ratio [OR] 1.53 [95% confidence interval (CI) 1.06-2.21], p = 0.02). By contrast, hypertension was an independent predictor of high degree of BG-DPVS (OR 9.4 [95% CI 1-85.2], p = 0.04).
CONCLUSIONS
The associations of WM-DPVS with lobar microbleeds and BG-DPVS with hypertension raise the possibility that the distribution of DPVS may indicate the presence of underlying small-vessel diseases such as cerebral amyloid angiopathy and hypertensive vasculopathy in patients with cognitive impairment.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2068810, encodeId=9826206881036, content=<a href='/topic/show?id=9da3203482c' target=_blank style='color:#2F92EE;'>#不同类型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20348, encryptionId=9da3203482c, topicName=不同类型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e7948, createdName=李研东, createdTime=Fri Nov 08 22:22:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999286, encodeId=fb4c199928622, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun May 26 08:22:00 CST 2013, time=2013-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644368, encodeId=928416443682f, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Wed Nov 13 19:22:00 CST 2013, time=2013-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715820, encodeId=49971e158200c, content=<a href='/topic/show?id=441b4e17253' target=_blank style='color:#2F92EE;'>#小血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47172, encryptionId=441b4e17253, topicName=小血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=956e32082497, createdName=clmlylxy, createdTime=Sun Dec 08 21:22:00 CST 2013, time=2013-12-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2068810, encodeId=9826206881036, content=<a href='/topic/show?id=9da3203482c' target=_blank style='color:#2F92EE;'>#不同类型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20348, encryptionId=9da3203482c, topicName=不同类型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e7948, createdName=李研东, createdTime=Fri Nov 08 22:22:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999286, encodeId=fb4c199928622, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun May 26 08:22:00 CST 2013, time=2013-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644368, encodeId=928416443682f, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Wed Nov 13 19:22:00 CST 2013, time=2013-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715820, encodeId=49971e158200c, content=<a href='/topic/show?id=441b4e17253' target=_blank style='color:#2F92EE;'>#小血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47172, encryptionId=441b4e17253, topicName=小血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=956e32082497, createdName=clmlylxy, createdTime=Sun Dec 08 21:22:00 CST 2013, time=2013-12-08, status=1, ipAttribution=)]
    2013-05-26 yinhl1978
  3. [GetPortalCommentsPageByObjectIdResponse(id=2068810, encodeId=9826206881036, content=<a href='/topic/show?id=9da3203482c' target=_blank style='color:#2F92EE;'>#不同类型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20348, encryptionId=9da3203482c, topicName=不同类型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e7948, createdName=李研东, createdTime=Fri Nov 08 22:22:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999286, encodeId=fb4c199928622, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun May 26 08:22:00 CST 2013, time=2013-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644368, encodeId=928416443682f, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Wed Nov 13 19:22:00 CST 2013, time=2013-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715820, encodeId=49971e158200c, content=<a href='/topic/show?id=441b4e17253' target=_blank style='color:#2F92EE;'>#小血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47172, encryptionId=441b4e17253, topicName=小血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=956e32082497, createdName=clmlylxy, createdTime=Sun Dec 08 21:22:00 CST 2013, time=2013-12-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2068810, encodeId=9826206881036, content=<a href='/topic/show?id=9da3203482c' target=_blank style='color:#2F92EE;'>#不同类型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20348, encryptionId=9da3203482c, topicName=不同类型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e7948, createdName=李研东, createdTime=Fri Nov 08 22:22:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999286, encodeId=fb4c199928622, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun May 26 08:22:00 CST 2013, time=2013-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644368, encodeId=928416443682f, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Wed Nov 13 19:22:00 CST 2013, time=2013-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715820, encodeId=49971e158200c, content=<a href='/topic/show?id=441b4e17253' target=_blank style='color:#2F92EE;'>#小血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47172, encryptionId=441b4e17253, topicName=小血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=956e32082497, createdName=clmlylxy, createdTime=Sun Dec 08 21:22:00 CST 2013, time=2013-12-08, status=1, ipAttribution=)]

相关资讯

Oncogene:p53亚型刺激血管生成和肿瘤发展

p53是一种肿瘤抑制基因(gene)。在所有恶性肿瘤中,50%以上会出现该基因的突变。由这种基因编码的蛋白质(protein)是一种转录(transcription)因子,其控制着细胞周期的启动。该基因编码一种分子量为53kDa的蛋白质,p53基因的失活对肿瘤形成起重要作用。 肿瘤抑制基因p53参与DNA修复、细胞周期阻滞和凋亡,也参与抑制血管的形成过程,血管生成对促进肿瘤的发展非常有帮助。p5

Exp Cell Res:多靶抑制肿瘤诱导的血管生成

实体瘤的生长和转移需要血管生成,以确保迅速分裂的肿瘤细胞能获得充足的氧气、营养物质和生长因子。 血管内皮生长因子(VEGF)的转录因子是由HIF刺激调控的一个典型例子。化疗或放疗能引起肿瘤组织的缺氧反应,而血管内皮生长因子通过诱导血管生成促进肿瘤的生长和生存,可见VEGF对肿瘤的生长时至关重要的,因此VEGF已成为一个诱人靶标来治疗中晚期肿瘤患者,具体表现在运用一些VEGF的抗体来治疗患者。

Asian J Androl:VEGFA的非促血管生成作用

在一些恶性肿瘤类型中,缺氧和转化生长因子-β1(转化生长因子-β1)能增加血管内皮生长因子(VEGFA)的表达。这种低氧和TGF-β1可能对晚期前列腺癌患者肿瘤的进展和转移具有关键影响。 近日,刊登在Asian Journal of Andrology杂志上的一则研究中,研究人员发现TGF-β1能诱导正常细胞株(HPV7和RWPE1)和前列腺癌的细胞株(DU145和PC3)分泌VEGFA(165

Cancer Res:微环境雌激素受体α有助促进血管正常化

雌激素直接促进表达雌激素受体α(ERα)乳腺癌的生长。然而,在肿瘤微环境中基质表达ERα对雌激素的促肿瘤作用具有什么样的贡献从未被探索。 近来,发表在Cancer Research杂志上一则新项研究中,研究人员探讨了了17β-雌二醇(E2)影响肿瘤微环境和调节ERα阴性肿瘤发展的细胞和分子机制。科学家选用不同的ER阴性肿瘤细胞移植到同系免疫去势小鼠皮下,结果发现素E2促进肿瘤的生长,增加肿瘤内血

Cancer Cell:促凋亡受体DR5破坏肿瘤血管

7月10日,Cancer Cell杂志报道,科学家发现促凋亡受体DR5可在肿瘤细胞微环境中促进凋亡,破坏肿瘤血管,为进一步治疗肿瘤创造了条件。 肿瘤细胞内的促凋亡受体DR5已被深入研究,但其在肿瘤微环境中的功能还没有很好地确定。本研究揭示了DR5信号在肿瘤血管内皮细胞(ECs)中的作用。研究发现在肿瘤内皮细胞中DR5存在表达,但不在正常的组织中表达。 给予荷瘤小鼠寡聚形式的DR5配体Apo2

Science:溶解阻塞血管的药物输送系统可减少副作用

研究人员设计了一种会模仿血小板行为并特别以一种溶解堵塞血管的阻塞的药物作为标靶的新的药物输送系统。受到血小板会被吸引到流体剪力高的地方并会自然迁移到狭窄的血管这一事实的启发,Netanel Korin及其同事给纳米颗粒团块裹了层可溶解阻塞的被称作组织型纤溶酶原激活物或tPA的药物,这些纳米颗粒被设计成会在这种情况下崩裂。相关研究成果刊登在国际杂志Science上。 其结果是形成一种被吸引至身体血